TRUP - Trupanion, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
32.81
-0.64 (-1.91%)
At close: 4:00PM EDT

32.81 0.00 (0.00%)
After hours: 4:39PM EDT

Stock chart is not supported by your current browser
Previous Close33.45
Open33.20
Bid32.35 x 1100
Ask34.48 x 800
Day's Range32.50 - 33.21
52 Week Range22.38 - 46.70
Volume196,051
Avg. Volume230,332
Market Cap1.143B
Beta (3Y Monthly)2.19
PE Ratio (TTM)N/A
EPS (TTM)-0.02
Earnings DateJul 31, 2019 - Aug 5, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est39.25
Trade prices are not sourced from all markets
  • 2 Stocks to Play the Pet Care Trend
    Motley Fool3 days ago

    2 Stocks to Play the Pet Care Trend

    With consumers spending as much as $72 billion on their pets in 2018, here are 2 companies that could benefit most from our love of animals.

  • 3 Top Insurance Stocks to Buy Now
    Motley Fool3 days ago

    3 Top Insurance Stocks to Buy Now

    These insurers could produce excellent returns in the coming years.

  • PR Newswire7 days ago

    Redfin and Trupanion Name the 25 Most Cat-Friendly Cities of 2019

    To determine the ranking, which looked at 250 cities nationwide, Trupanion analyzed its data on access to cat-specific services such as clinics, shelters and hospitals, as well as environmental hazards. Redfin calculated the percentage of homes for sale with cat-friendly features such as high ceilings for room to climb, an extra bathroom for storing litter boxes, and patios for those who'd like to create safe outdoor spaces for their cat.

  • GlobeNewswire10 days ago

    Trupanion Lights Up Times Square for Veterinary Appreciation Day

    Trupanion (Nasdaq: TRUP), a leader in medical insurance for cats and dogs, will be in Times Square on Veterinary Appreciation Day (Tuesday, June 18) to light up the Nasdaq Tower’s seven-story LED Display board in recognition of veterinary professionals across North America. “Trupanion was founded with the input and support of veterinarians, and they remain a core part of our business today,” said Margi Tooth, Chief Revenue Officer at Trupanion.

  • ETF Trends24 days ago

    Inside The Potential Potency of Pet Stocks

    The ProShares Pet Care ETF (CBOE:PAWZ) debuted last November as the first exchange traded fund (ETF) dedicated to the pet care industry and related investment opportunities. While PAWZ does not have a lengthy track record, it is already proving to be a durable ETF amid increased equity market volatility. Last month, the S&P 500 slid 5.67%, but PAWZ lost just 1.51%.

  • GlobeNewswire24 days ago

    Trupanion to Host 2019 Annual Meeting of Stockholders June 6th

    Trupanion, Inc. (Nasdaq: TRUP), a leading provider of medical insurance for cats and dogs, will host its Annual Meeting of Stockholders on Thursday, June 6, 2019.  The Annual Meeting will be held at Trupanion’s corporate headquarters, located at 6100 4th Avenue South, Suite 200, Seattle, Washington 98108. This annual event is designed to be the best opportunity for Trupanion stockholders and guests to understand Trupanion’s achievements and challenges over the past 12 months and its strategic vision going forward.  Stockholders and guests will have an opportunity for direct Q&A with the team, listen to presentations from management, and be provided tours of Trupanion’s newly acquired headquarters.  Doors will open at 8:00 AM PT, with the formal meeting to begin at approximately 9:00 AM PT.

  • American City Business Journals28 days ago

    Revealed: PSBJ inaugural Middle Market Fast 50 list makers

    The companies on this list are a mix of public and private, and had revenue between $25 million and $1 billion in 2018. Together, they brought in $16.6 billion in revenue last year and employed more than 15,250 in the state and nearly 47,000 globally.

  • How Much is Trupanion, Inc.'s (NASDAQ:TRUP) CEO Getting Paid?
    Simply Wall St.last month

    How Much is Trupanion, Inc.'s (NASDAQ:TRUP) CEO Getting Paid?

    Darryl Graham Rawlings has been the CEO of Trupanion, Inc. (NASDAQ:TRUP) since 2000. This analysis aims first to...

  • InvestorPlacelast month

    You Can Get Buy Signals From Short Selling

    You may be surprised to hear this, but a large amount of short interest in a stock could actually be a buy signal.What is short selling a stock? It's selling a stock that you don't own with the intention of buying it back at a lower price in the future, usually using options. And short interest is the number of shares that are sold short that haven't been bought back yet. It is usually expressed as a ratio of shares that are short to the total number of outstanding shares.The short interest can also be expressed as "Days to Cover." This is the number of short shares divided by the average daily trading volume. In other words, it is the number of days that it would take for all the short shares to be bought back.InvestorPlace - Stock Market News, Stock Advice & Trading TipsI should note, this number should be considered understated, because it assumes purchasing 100% of the volume. This would be impossible in normal markets. It would be more realistic to assume that short sellers could only buy about 10%-15% of the average daily volume with adversely affecting the price. * 7 Safe Stocks to Buy for Anxious Investors You should pay attention to this because really high short-interest could be a bullish signal. This is because these shares need to be bought back. These short-sellers will all eventually become buyers! Trupanion (TRUP)Trupanion (NASDAQ:TRUP) provides medical insurance for cats and dogs. It has a subscription business and also offers insurance to companies that can provide it as a benefit to their employees.There are about 11.2 million shares currently short. This is 38% of the outstanding float. The average daily volume recently is about 145,000. That means the days to cover would be about 77. And remember, that assumes buying 100% of the volume.It would be more realistic to assume that one could only trade about 10% of the volume without adversely affecting the price. That means it could take years for the shorts to cover all of their positions!Wall Street seems to disagree with the shorts. Six firms follow it and the all have buy ratings on it. The average price target is $40. Accelerate Diagnostics (AXDX)Accelerate Diagnostics (NASDAQ:AXDX) engages in developing and selling instruments that are used to fight infectious pathogens.There are 14.1 million shares currently short in this company. That is 52% of the float. That means that there are guaranteed buyers for about half of the company's stock! Assuming that they buy 10% of the average daily volume, it would take about two years to cover it. * 7 Stocks to Buy for Over 20% Upside Potential All four of the analysts who cover this have a buy rating on it according to Yahoo Finance. OptiNose (OPTN)OptiNose (NASDAQ:OPTN) develops and sells products that are for the treatment of ear, nose, throat and allergy illnesses.The short-interest is 7.9 million, or about 49% of the float. Over the past year, the price of the stock has fallen from $30 to current levels around $9.Wall Street doesn't feel as bad about this company's prospects as the short sellers do. It likes this stock. All four analysts that follow it have it rated as a buy and the average target price is $25. That is about three times higher then where it is currently trading. Energy Recovery (ERII)Energy Recovery (NASDAQ:ERII) develops and sells products that are for industrial fluid flow application. Their customers include oil and gas companies.5.5 million shares are currently short. That is about 14% of the float. It isn't as much as the other companies, but it is still pretty high. It only trades about 112,000 on a typical day, so that would give a days to cover number of about 50. Using our estimate of being able to only acquire about 10%-15% of the volume that trades with adversely affecting the price, it would take over a year to cover. * 7 High-Yield REITs to Buy (Even When the Market Tanks) There are six buys on this company. The average target price is about $16, which is about 60% above current prices. Seres Therapeutics (MCRB)Seres Therapeutics (NASDAQ:MCRB) creates medicines "using live bacteria to treat diseases that result from functional deficiencies in the microbiome."The share price fell dramatically over the past month. The current short interest is 5.3 million of the float. That is about 25%. With an average daily volume of about 111,000, the days to cover is 48.This company is followed by nine Wall Street firms. Seven have it rated as a buy and the other two have it as a hold. The average target price is $11 and it is currently trading below $5. Theravance Biopharma (TBPH)Theravance Biopharma (NASDAQ:TBPH) is a biopharmaceutical company. It focuses and the research, development and commercialization of small molecule medicines.The short-interest ratio here is "only" 15%, or 6.3 million shares. The stock only trades about 154,000 shares on a typical day, so that is 41 days to cover.Remember, it is safe to assume that they can buy about 10% of the volume without adversely affecting the price. * 6 Chinese Stocks That Could Pop On a Trade Deal Seven firms follow this company. Four of them have it rated a buy and three have it as a sell. The average target price is just over $38 per share.As of this writing, Mark Putrino did not hold a position in any of the aforementioned securities. More From InvestorPlace * 4 Top American Penny Pot Stocks (Buy Before June 21) * 7 Safe Stocks to Buy for Anxious Investors * 4 Tech Stocks Looking Vulnerable * Should You Buy, Sell, Or Hold These 7 Hot IPO Stocks? Compare Brokers The post You Can Get Buy Signals From Short Selling appeared first on InvestorPlace.

  • GlobeNewswirelast month

    Trupanion Announces Upcoming Investor Conference Participation

    SEATTLE, May 21, 2019 -- Trupanion, Inc. (Nasdaq: TRUP) announced today that members of Trupanion’s management team will participate in two upcoming investor conferences:.

  • Thomson Reuters StreetEvents2 months ago

    Edited Transcript of TRUP earnings conference call or presentation 2-May-19 8:30pm GMT

    Q1 2019 Trupanion Inc Earnings Call

  • Trupanion Keeps Adding Pets, but at a Cost
    Motley Fool2 months ago

    Trupanion Keeps Adding Pets, but at a Cost

    Will these investments pay off?

  • Is Trupanion Inc (TRUP) A Good Stock To Buy?
    Insider Monkey2 months ago

    Is Trupanion Inc (TRUP) A Good Stock To Buy?

    "Market conditions are changing. The continued rise in interest rates suggests we are in the early stages of a bond bear market, which could intensify as central banks withdraw liquidity. The receding tide of liquidity will start to reveal more rocks beyond what has been exposed in emerging markets so far, and the value of […]

  • GlobeNewswire2 months ago

    Trupanion Launches in Australia, Marking Its Expansion Outside of North America

    Trupanion (NASDAQ:TRUP), a leader in medical insurance for cats and dogs in the U.S. and Canada, announced today its expansion into Australia. The Australia launch is the first major overseas move for Trupanion outside of North America. “This is another important milestone in the history of our company,” said Darryl Rawlings, chief executive officer and founder of Trupanion.

  • Trupanion Inc (TRUP) Q1 2019 Earnings Call Transcript
    Motley Fool2 months ago

    Trupanion Inc (TRUP) Q1 2019 Earnings Call Transcript

    TRUP earnings call for the period ending March 31, 2019.

  • Trupanion (TRUP) Reports Q1 Loss, Tops Revenue Estimates
    Zacks2 months ago

    Trupanion (TRUP) Reports Q1 Loss, Tops Revenue Estimates

    Trupanion (TRUP) delivered earnings and revenue surprises of -300.00% and 1.23%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

  • GlobeNewswire2 months ago

    Trupanion Reports First Quarter 2019 Results

    SEATTLE, May 02, 2019 -- Trupanion, Inc. (Nasdaq: TRUP), a leading provider of medical insurance for cats and dogs, today announced financial results for the first quarter.

  • GlobeNewswire2 months ago

    Trupanion Launches in Australia with a No Payout Limit, 24/7 Insurance Plan to Disrupt Australian Pet Insurance Market

    Trupanion (NASDAQ:TRUP), a leader in medical insurance for cats and dogs in the U.S. and Canada, has launched into Australia, looking to disrupt the Australian pet insurance market. Launching into the Australia market is the first expansion outside of North America for the Seattle-based company. Experienced Veterinarian and General Manager Dr. Stephen Rose will lead the company into the Australian marketplace.

  • GlobeNewswire2 months ago

    Trupanion Announces Date of 2019 Annual Meeting of Stockholders

    Trupanion, Inc. (Nasdaq: TRUP), a leading provider of medical insurance for cats and dogs, will host its Annual Meeting of Stockholders on Thursday, June 6, 2019.  The Annual Meeting will be held at Trupanion’s corporate headquarters, located at 6100 4th Avenue South, Suite 200, Seattle, Washington 98108. This annual event is designed to be the best opportunity for Trupanion stockholders and guests to understand Trupanion’s achievements and challenges over the past 12 months and its strategic vision going forward.  Stockholders and guests will have an opportunity for direct Q&A with the team, listen to presentations from management, and be provided tours of Trupanion’s newly acquired headquarters.  Doors will open at 8:00 AM PT, with the formal meeting to begin at 9:00 AM PT.

  • Trupanion (TRUP) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
    Zacks2 months ago

    Trupanion (TRUP) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

    Trupanion (TRUP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • Accident and Health Insurance Near-Term Prospects Bright
    Zacks2 months ago

    Accident and Health Insurance Near-Term Prospects Bright

    Accident and Health Insurance Near-Term Prospects Bright

  • GlobeNewswire2 months ago

    Putting Nutrition to the Test: Trupanion and Rayne Clinical Nutrition Join Forces

    Trupanion, Inc. (Nasdaq: TRUP), a leader in medical insurance for cats and dogs, and Rayne Clinical Nutrition, a provider of therapeutic diets for pets, have announced the start of a new partnership. “We’re eager to understand if feeding a high quality diet will have a better health outcome for a pet,” said Darryl Rawlings, chief executive officer/founder of Trupanion. Trupanion’s medical insurance for cats and dogs helps pet owner’s budget if/when their pet becomes sick or injured.

  • GlobeNewswire2 months ago

    Trupanion, Inc. Announces First Quarter 2019 Earnings Release and Conference Call

    Trupanion, Inc. (TRUP), a leading provider of medical insurance for cats and dogs, announced today it will report financial results for its 2019 first quarter after the market closes on Thursday, May 2, 2019. A live webcast will be available on Trupanion's Investor Relations site under Investor Events at http://investors.trupanion.com and will be archived online for 3 months upon completion of the conference call. Participants can access the conference call by dialing 1-877-407-0784 (United States) or 1-201-689-8560 (International).

  • What You Must Know About Trupanion, Inc.'s (NASDAQ:TRUP) Beta Value
    Simply Wall St.3 months ago

    What You Must Know About Trupanion, Inc.'s (NASDAQ:TRUP) Beta Value

    Want to participate in a research study? Help shape the future of investing tools and earn a $60 gift card! If you're interested in Trupanion, Inc. (NASDAQ:TRUP), then you might want to consider its beta (a measure of share price vol...

  • Why Trupanion Stock Gained 14.3% in February
    Motley Fool4 months ago

    Why Trupanion Stock Gained 14.3% in February

    The pet insurance company's stock has tripled over the last three years.